Skip to main content
Top
Published in: Archives of Virology 4/2015

01-04-2015 | Original Article

A multi-species indirect ELISA for detection of non-structural protein 3ABC specific antibodies to foot-and-mouth disease virus

Authors: M. Hosamani, S. H. Basagoudanavar, R. P. Tamil Selvan, Varsha Das, Pravina Ngangom, B. P. Sreenivasa, Raveendra Hegde, R. Venkataramanan

Published in: Archives of Virology | Issue 4/2015

Login to get access

Abstract

Reliable diagnostic tests that are able to distinguish infected from vaccinated animals are a critical component of regional control programs for foot-and-mouth disease (FMD) in the affected countries. Non-structural protein (NSP) serology based on the 3ABC protein has been widely used for this purpose, and several kits are commercially available worldwide. This report presents the development of a 3ABC-antigen-based indirect ELISA, employing a peroxidase-conjugated protein G secondary antibody that can detect antibodies from multiple species. Recombinant 3ABC protein was expressed in insect cells and purified using affinity column chromatography. Using this protein, an indirect ELISA was developed and validated for the detection of NSP antibodies in serum samples collected from animals with different status of FMD. Diagnostic sensitivity and specificity were found to be 95.8 (95 % CI: 92.8–97.8) and 97.45 % (95 % CI: 94.8–99.0), respectively. The in-house ELISA compared well with the commercially available prioCHECK FMDV NS-FMD kit, with a high agreement between the tests, as determined by the kappa coefficient, which was 0.87. The in-house ELISA showed higher sensitivity for detecting vaccinated and subsequently infected animals, when compared to the reference test. Both of the tests were able to detect NSP antibodies as early as 7–8 days after experimental infection.
Literature
1.
go back to reference Anon (2012) Global strategy for control of foot-and-mouth disease, Bangkok, pp 27–29 Anon (2012) Global strategy for control of foot-and-mouth disease, Bangkok, pp 27–29
2.
go back to reference Rweyemamu M, Roeder P, MacKay D, Sumption K, Brownlie J, Leforban Y (2008) Planning for the progressive control of foot-and-mouth disease worldwide. Transbound Emerg Dis 55(1):73–87CrossRefPubMed Rweyemamu M, Roeder P, MacKay D, Sumption K, Brownlie J, Leforban Y (2008) Planning for the progressive control of foot-and-mouth disease worldwide. Transbound Emerg Dis 55(1):73–87CrossRefPubMed
4.
go back to reference Grubman MJ, Zellner M, Bablanian G, Mason PW, Piccone ME (1995) Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus. Virology 213(2):581–589CrossRefPubMed Grubman MJ, Zellner M, Bablanian G, Mason PW, Piccone ME (1995) Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus. Virology 213(2):581–589CrossRefPubMed
5.
go back to reference Srisombundit V, Tungthumniyom N, Linchongsubongkoch W, Lekcharoensuk C, Sariya L, Ramasoota P, Lekcharoensuk P (2013) Development of an inactivated 3C(pro)-3ABC (mu3ABC) ELISA to differentiate cattle infected with foot and mouth disease virus from vaccinated cattle. J Virol Methods 188(1–2):161–167CrossRefPubMed Srisombundit V, Tungthumniyom N, Linchongsubongkoch W, Lekcharoensuk C, Sariya L, Ramasoota P, Lekcharoensuk P (2013) Development of an inactivated 3C(pro)-3ABC (mu3ABC) ELISA to differentiate cattle infected with foot and mouth disease virus from vaccinated cattle. J Virol Methods 188(1–2):161–167CrossRefPubMed
6.
go back to reference Moonen P, van der Linde E, Chénard G, Dekker A (2004) Comparable sensitivity and specificity in three commercially available ELISAs to differentiate between cattle infected with or vaccinated against foot-and-mouth disease virus. Vet Microbiol 99(2):93–101CrossRefPubMed Moonen P, van der Linde E, Chénard G, Dekker A (2004) Comparable sensitivity and specificity in three commercially available ELISAs to differentiate between cattle infected with or vaccinated against foot-and-mouth disease virus. Vet Microbiol 99(2):93–101CrossRefPubMed
7.
go back to reference Jaworski JP, Compaired D, Trotta M, Perez M, Trono K, Fondevila N (2011) Validation of an r3AB1-FMDV-NSP ELISA to distinguish between cattle infected and vaccinated with foot-and-mouth disease virus. J Virol Methods 178(1–2):191–200CrossRefPubMed Jaworski JP, Compaired D, Trotta M, Perez M, Trono K, Fondevila N (2011) Validation of an r3AB1-FMDV-NSP ELISA to distinguish between cattle infected and vaccinated with foot-and-mouth disease virus. J Virol Methods 178(1–2):191–200CrossRefPubMed
8.
go back to reference De Diego M, Brocchi E, Mackay D, De Simone F (1997) The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch Virol 142(10):2021–2033CrossRefPubMed De Diego M, Brocchi E, Mackay D, De Simone F (1997) The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch Virol 142(10):2021–2033CrossRefPubMed
9.
go back to reference Paton DJ, de Clercq K, Greiner M, Dekker A, Brocchi E, Bergmann I, Sammin DJ, Gubbins S, Parida S (2006) Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle. Vaccine 24(42–43):6503–6512CrossRefPubMed Paton DJ, de Clercq K, Greiner M, Dekker A, Brocchi E, Bergmann I, Sammin DJ, Gubbins S, Parida S (2006) Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle. Vaccine 24(42–43):6503–6512CrossRefPubMed
10.
go back to reference Brocchi E, Bergmann IE, Dekker A, Paton DJ, Sammin DJ, Greiner M, Grazioli S, De Simone F, Yadin H, Haas B, Bulut N, Malirat V, Neitzert E, Goris N, Parida S, Sørensen K, De Clercq K (2006) Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Vaccine 24(47–48):6966–6979CrossRefPubMed Brocchi E, Bergmann IE, Dekker A, Paton DJ, Sammin DJ, Greiner M, Grazioli S, De Simone F, Yadin H, Haas B, Bulut N, Malirat V, Neitzert E, Goris N, Parida S, Sørensen K, De Clercq K (2006) Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Vaccine 24(47–48):6966–6979CrossRefPubMed
11.
go back to reference Mackay D, Parida S, Paton D, Anderson J (2004) Making a vaccinate-to-live policy a reality in foot-and-mouth disease. Dev Biol (Basel) 119:261–266 Mackay D, Parida S, Paton D, Anderson J (2004) Making a vaccinate-to-live policy a reality in foot-and-mouth disease. Dev Biol (Basel) 119:261–266
12.
go back to reference Barnett PV, Geale DW, Clarke G, Davis J, Kasari TR (2013) A review of OIE country status recovery using vaccinate-to-live versus vaccinate-to-die foot-and-mouth disease response policies I: benefits of higher potency vaccines and associated NSP DIVA test systems in post-outbreak surveillance. Transbound Emerg Dis. doi:10.1111/tbed.12166 Barnett PV, Geale DW, Clarke G, Davis J, Kasari TR (2013) A review of OIE country status recovery using vaccinate-to-live versus vaccinate-to-die foot-and-mouth disease response policies I: benefits of higher potency vaccines and associated NSP DIVA test systems in post-outbreak surveillance. Transbound Emerg Dis. doi:10.​1111/​tbed.​12166
13.
go back to reference Parida S, Fleming L, Gibson D, Hamblin PA, Grazioli S, Brocchi E, Paton DJ (2007) Bovine serum panel for evaluating foot-and-mouth disease virus nonstructural protein antibody tests. J Vet Diagn Invest 19:539–544CrossRefPubMed Parida S, Fleming L, Gibson D, Hamblin PA, Grazioli S, Brocchi E, Paton DJ (2007) Bovine serum panel for evaluating foot-and-mouth disease virus nonstructural protein antibody tests. J Vet Diagn Invest 19:539–544CrossRefPubMed
14.
go back to reference Uttenthal A, Parida S, Rasmussen TB, Paton DJ, Haas B, Dundon WG (2010) Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza. Expert Rev Vaccines 9(1):73–87CrossRefPubMed Uttenthal A, Parida S, Rasmussen TB, Paton DJ, Haas B, Dundon WG (2010) Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza. Expert Rev Vaccines 9(1):73–87CrossRefPubMed
15.
go back to reference Sørensen KJ, de Stricker K, Dyrting KC, Grazioli S, Haas B (2005) Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody. Arch Virol 150(4):805–814CrossRefPubMed Sørensen KJ, de Stricker K, Dyrting KC, Grazioli S, Haas B (2005) Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody. Arch Virol 150(4):805–814CrossRefPubMed
16.
go back to reference Sørensen KJ, Madsen KG, Madsen ES, Salt JS, Nqindi J, Mackay DK (1998) Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus. Arch Virol 143(8):1461–1476CrossRefPubMed Sørensen KJ, Madsen KG, Madsen ES, Salt JS, Nqindi J, Mackay DK (1998) Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus. Arch Virol 143(8):1461–1476CrossRefPubMed
17.
go back to reference Mohapatra JK, Pandey LK, Sanyal A, Pattnaik B (2011) Recombinant non-structural polyprotein 3AB-based serodiagnostic strategy for FMD surveillance in bovines irrespective of vaccination. J Virol Methods 177(2):184–192CrossRefPubMed Mohapatra JK, Pandey LK, Sanyal A, Pattnaik B (2011) Recombinant non-structural polyprotein 3AB-based serodiagnostic strategy for FMD surveillance in bovines irrespective of vaccination. J Virol Methods 177(2):184–192CrossRefPubMed
18.
go back to reference Kumar R, Hosamani M, Sreenivasa BP, Kotyal A, Venkataramanan R (2012) Expression of foot-and-mouth disease non-structural protein, 3D in insect cells and its application in detection of anti-FMDV antibodies. Indian J Virol 23(3):326–332CrossRefPubMedCentralPubMed Kumar R, Hosamani M, Sreenivasa BP, Kotyal A, Venkataramanan R (2012) Expression of foot-and-mouth disease non-structural protein, 3D in insect cells and its application in detection of anti-FMDV antibodies. Indian J Virol 23(3):326–332CrossRefPubMedCentralPubMed
19.
go back to reference Espinoza AM, Maradei E, Mattion N, Cadenazzi G, Maddonni G, Robiolo B, La Torre J, Bellinzoni R, Smitsaart E (2004) Foot-and-mouth disease polyvalent oil vaccines inoculated repeatedly in cattle do not induce detectable antibodies to non-structural proteins when evaluated by various assays. Vaccine 23(1):69–77CrossRefPubMed Espinoza AM, Maradei E, Mattion N, Cadenazzi G, Maddonni G, Robiolo B, La Torre J, Bellinzoni R, Smitsaart E (2004) Foot-and-mouth disease polyvalent oil vaccines inoculated repeatedly in cattle do not induce detectable antibodies to non-structural proteins when evaluated by various assays. Vaccine 23(1):69–77CrossRefPubMed
20.
go back to reference Kumar N, Sharma R, Kakker NK (2007) Non-structural protein 3A for differentiation of foot-and-mouth disease infected and vaccinated animals in Haryana (India). Zoonoses Public Health 54(9–10):376–382CrossRefPubMed Kumar N, Sharma R, Kakker NK (2007) Non-structural protein 3A for differentiation of foot-and-mouth disease infected and vaccinated animals in Haryana (India). Zoonoses Public Health 54(9–10):376–382CrossRefPubMed
Metadata
Title
A multi-species indirect ELISA for detection of non-structural protein 3ABC specific antibodies to foot-and-mouth disease virus
Authors
M. Hosamani
S. H. Basagoudanavar
R. P. Tamil Selvan
Varsha Das
Pravina Ngangom
B. P. Sreenivasa
Raveendra Hegde
R. Venkataramanan
Publication date
01-04-2015
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 4/2015
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-015-2339-9

Other articles of this Issue 4/2015

Archives of Virology 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.